CAS RN: 539-17-3
4-Amino-4′-dimethylaminoazobenzene
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20260416
200mg / 1g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 539-17-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥97%
0
Out of Stock
Shenzhen
Inquiry
539-17-3 / 4-[[4-(dimethylamino)phenyl]diazenyl]aniline
Standard CAS: 539-17-3
Multi CAS: No
Basic Information
copy
CAS
539-17-3 copy
Multi CAS
No copy
Molecular Formula
C14H16N4 copy
Molecular Weight
240.300000 copy
Exact Mass
240.137497 copy
InChI
InChI=1S/C14H16N4/c1-18(2)14-9-7-13(8-10-14)17-16-12-5-3-11(15)4-6-12/h3-10H,15H2,1-2H3 copy
InChIKey
BVRIUXYMUSKBHG-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.14 copy
Rotatable bonds
3 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
75.8 copy
TPSA
53.98 copy
LogP / Solubility
WLOGP
3.75 copy
MLOGP
3.31 copy
XLogP3
3.9 copy
Consensus LogP
3.65 copy
Log S (ESOL)
-3.99 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.24 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.69 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
PAINS alerts
1 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy